EpitalON Capsules: Benefits, Dosage & Research Explained | Mandimart

Of all the peptide bioregulators that have emerged from decades of Russian research, EpitalON has attracted perhaps the most attention from longevity researchers and biohackers alike. Part of this fascination stems from its association with the pineal gland – often called the "third eye" due to its role in circadian rhythms – and part from an extensive body of research dating back to the 1980s. But what exactly is this tetrapeptide, and what does the research actually show, and how is it typically used?

This comprehensive guide examines EpitalON (also known as epitalon, epithalon, or epithalamin), a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG) that has been studied since the 1980s at the St Petersburg Institute of Bioregulation and Gerontology. Ready to use oral capsules, YourProtocol EpitalON is available through MandiMart. We'll also explore what research has revealed about this peptide bioregulator, while being clear about both the evidence and its limitations.

What is EpitalON?

EpitalON is a tetrapeptide, meaning it consists of four amino acids linked together: Alanine, Glutamic Acid, Aspartic Acid, and Glycine. Sometimes abbreviated as AEDG after the single-letter codes for these amino acids, this sequence creates a remarkably small peptide with a molecular weight of approximately 390 daltons.

The peptide represents a synthetic version of a fragment of epithalamin, a polypeptide originally isolated from the pineal gland by Professor Vladimir Khavinson and his colleagues at the St Petersburg Institute of Bioregulation and Gerontology. Since the 1980s, this research group has published extensively on EpitalON and related peptides, generating a substantial body of literature spanning cell culture studies, animal experiments, and small human trials.

According to Khavinson's bioregulator concept, short peptides like EpitalON are thought to interact with regulatory regions of DNA in specific tissues. The theory suggests these peptides may influence gene expression through epigenetic mechanisms, though the precise molecular interactions remain an area of ongoing investigation. EpitalON is specifically associated with the pineal gland, the small endocrine gland that produces melatonin and helps regulate circadian rhythms.

YourProtocol's EpitalON is formulated as oral capsules, with each capsule containing 3mg of the AEDG tetrapeptide complex. This represents a departure from most published research, which has primarily used injectable forms, though the debate about oral versus injectable administration continues within the research community.

The Research: What Studies Have Found

Important compliance note: The following section describes research findings from published studies. These are presented for educational purposes only, as observations from scientific literature, not as claims about what EpitalON will do for any individual. EpitalON is not approved as a medicine in the UK or EU.

Telomere and Telomerase Research

Much of the scientific interest in EpitalON stems from research investigating its relationship to telomerase activity and telomere length. In a frequently cited 2003 study published in the Bulletin of Experimental Biology and Medicine, Khavinson and colleagues reported that EpitalON induced telomerase activity and telomere elongation in human somatic cells cultured in vitro. The researchers observed that cells treated with the peptide showed increased proliferative lifespan beyond the typical Hayflick limit.

A 2025 study published in Biogerontology provided independent confirmation of these findings, demonstrating dose-dependent telomere length extension in normal human cells through upregulation of hTERT (human telomerase reverse transcriptase) mRNA expression. Interestingly, this study also found that in cancer cell lines, telomere extension occurred through activation of the ALT (Alternative Lengthening of Telomeres) pathway rather than telomerase, suggesting cell-type-specific mechanisms.

Melatonin and Circadian Research

Studies have investigated EpitalON's relationship to melatonin synthesis and circadian markers. A 2013 in vitro study by Sibarov and colleagues examined the effects on rat pineal cells, reporting increased expression of key enzymes involved in melatonin biosynthesis. Research in aged rhesus monkeys reported restoration of evening melatonin peaks and the normalization of circadian cortisol rhythms following EpitalON administration.

Immune System Markers

A 2002 in vitro study investigated the effects of EpitalON on interleukin-2 mRNA synthesis in mouse thymocytes. The researchers reported modulation of immune-related gene expression, though the clinical significance of these findings remains to be established.

Animal Lifespan Studies

Anisimov and colleagues have published several studies examining EpitalON's effects on lifespan in various animal models. These include research on CBA mice, where the peptide was associated with reduced spontaneous tumour incidence and extended maximum lifespan. A study in female SHR mice reported a 12.3% increase in maximum lifespan, with concurrent reduction in chromosome aberrations. It's important to note that these are animal studies, and results from animal research don't automatically translate to humans.

Important Caveats About the Research

Several important limitations should be acknowledged when reviewing the EpitalON literature:

• The majority of published studies originate from Khavinson's research group or closely affiliated laboratories

• Independent replication outside Russia has been limited, though the 2025 Biogerontology study represents a notable exception

• Human clinical data remains sparse, consisting mainly of small studies from one research group

• Most research has used injectable EpitalON, not oral formulations

• The peptide is not approved as a medicine in the UK, EU, or US

How EpitalON Capsules Are Typically Taken

Research Protocol Context 

The research literature commonly references cycles of 10-20 days at 5-10mg daily, repeated periodically (such as once or twice yearly). These protocols were developed for injectable forms in research settings. For example:

• The "Russian Protocol" described in some literature involves 10mg daily for 10 consecutive days

• The "Ukrainian Protocol" uses 10mg on days 1, 5, 9, 13, and 17

• Both protocols suggest repeating cycles every 4-6 months

These are research protocol descriptions, not recommendations for use.

YourProtocol EpitalON capsules contain 3mg per capsule, with 30 capsules per bottle. The product information suggests typical research protocols might involve 1-2 capsules daily, though specific protocols vary across studies.

An important consideration is that most published research uses injectable EpitalON, while YourProtocol offers an oral formulation. The oral bioavailability of peptides is a subject of ongoing scientific debate. Some researchers argue that peptides are largely degraded in the gastrointestinal tract, resulting in minimal absorption. Others, including proponents of oral peptide formulations, suggest that short peptides like EpitalON may retain some activity when taken orally, particularly when formulated appropriately.

This represents an honest scientific debate rather than a settled question. YourProtocol's position aligns with a growing body of work on oral peptide formulations, though researchers should be aware that oral bioavailability is typically lower than injectable routes.

The timing of administration varies in the research literature. Some protocols specify evening dosing (aligned with the pineal gland's circadian focus), while others suggest morning administration. As with all research compounds, individuals should consult with their healthcare practitioner before considering any peptide regimen.

EpitalON vs PinealON: A Quick Orientation

While both are peptide bioregulators from YourProtocol, EpitalON and PinealON have distinct profiles:

EpitalON (Ala-Glu-Asp-Gly)

• Associated with the pineal gland

• Research focus on circadian rhythms and neuroendocrine function

• Tetrapeptide structure (4 amino acids)

• Studied for telomerase activity

PinealON (Glu-Asp-Arg)

• Associated with brain and central nervous system

• Research focus on cognitive function

• Tripeptide structure (3 amino acids)

• Studied for neuroprotective properties

Many people interested in peptide bioregulators use both, sometimes referred to as the "Dual-System Protocol" by YourProtocol. For more detailed information about PinealON, see our companion guide on PinealON peptide.

Who Considers EpitalON?

People interested in EpitalON typically include:

• Those exploring peptide bioregulators as part of a broader approach to healthy ageing

• Biohackers and longevity enthusiasts familiar with Khavinson's research

• Individuals interested in circadian rhythm support

• People already using other YourProtocol peptides

Important cautions: EpitalON should not be used by anyone under 18 years of age, pregnant or breastfeeding women, or those on medication without consulting their healthcare practitioner. Anyone with hormonal conditions or pineal gland issues should specifically consult with a qualified practitioner, as the pineal gland is hormonally active and plays important regulatory roles.

What's Inside YourProtocol EpitalON

Each capsule contains:

Active Ingredient: Ala-Glu-Asp-Gly tetrapeptide complex: 3mg per capsule

Other Ingredients: Rice flour (bulking agent), Vegetable cellulose capsule, May contain additional excipients for stability

Free From: Synthetic fillers, Artificial additives, Preservatives, Gluten, Dairy, Soy

YourProtocol EpitalON is manufactured in a cGMP-certified facility in the United States and undergoes third-party testing for purity and potency. Each batch comes with certificates of analysis available upon request.

Frequently Asked Questions

What is EpitalON? Is it the same as Epithalon or Epithalamin?

EpitalON, epithalon, and epitalon are different names for the same synthetic tetrapeptide (AEDG). Epithalamin, however, is different – it's the natural polypeptide extract from the pineal gland that EpitalON was designed to mimic. EpitalON is the synthetic, standardised version.

Is oral EpitalON as effective as injectable?

This remains a subject of scientific debate. Most published research has used injectable forms, which bypass the digestive system. Oral peptides face challenges from stomach acid and digestive enzymes. However, some researchers argue that short peptides like EpitalON may retain activity when taken orally. The bioavailability is likely lower than injectable forms, but the convenience of oral administration may offset this for some applications.

How is EpitalON different from PinealON?

While both are bioregulator peptides, they have different amino acid sequences and research associations. EpitalON (AEDG) is a tetrapeptide associated with pineal gland function and circadian rhythms. PinealON (EDR) is a tripeptide associated with brain and cognitive function. They're often used together in what YourProtocol calls the "Dual-System Protocol."

How long does a bottle of EpitalON 3mg last?

With 30 capsules per bottle, duration depends on the protocol followed. At one capsule daily, a bottle would last 30 days. At two capsules daily, it would last 15 days. Research protocols vary, with some using cyclic patterns rather than continuous daily use.

Can I take EpitalON and PinealON together?

According to YourProtocol, many people use both peptides as part of their "Dual-System Protocol." However, anyone considering peptide use should consult with a qualified healthcare practitioner familiar with peptide bioregulators.

Is EpitalON legal to buy in the UK?

EpitalON is not approved as a medicine in the UK. It's sold as a research compound or food supplement, depending on the vendor's classification. UK regulations are complex and evolving – purchasers should ensure they understand current regulations.

Where is YourProtocol EpitalON manufactured?

According to YourProtocol, their EpitalON is manufactured in a cGMP-certified facility in the United States and undergoes third-party testing for purity.

Does EpitalON have side effects?

Published research has reported few adverse effects, though most studies have been small and short-term. As with any supplement, individual responses vary. Anyone experiencing unexpected effects should discontinue use and consult a healthcare practitioner.

Final Thoughts on EpitalON

EpitalON represents one of the most extensively studied peptide bioregulators, with research spanning over three decades. While the body of literature is substantial, it's important to acknowledge that much of it originates from a single research group, and independent replication remains limited. The availability of oral capsule formulations through YourProtocol offers convenience, though questions about oral bioavailability versus injectable forms remain part of ongoing scientific discussion.

For those interested in exploring peptide bioregulators, visit our YourProtocol collection at MandiMart to view EpitalON capsules and the complete range of bioregulator peptides. We also recommend reading our companion piece on PinealON for a complete understanding of YourProtocol's bioregulator range.

Disclaimer: This article is for educational and informational purposes only. EpitalON is not approved as a medicine in the UK or EU. The information presented here describes research findings and should not be construed as medical advice or claims about therapeutic benefits. Always consult with a qualified healthcare practitioner before starting any new supplement regimen.